Global Vaccines Market Overview And Scope:
Global Vaccines Market Size was estimated at USD 45016.66 million in 2022 and is projected to reach USD 62623.64 million by 2028, exhibiting a CAGR of 5.66% during the forecast period.
The Global Vaccines Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Vaccines utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, JandJ(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan
Global Vaccines Market Segmentation
By Type, Vaccines market has been segmented into:Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
By Application, Vaccines market has been segmented into:
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Vaccines market.
Top Key Players Covered in Vaccines market are:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
JandJ(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Objective to buy this Report:
1. Vaccines analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Vaccines market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Vaccines Market by Type
5.1 Vaccines Market Overview Snapshot and Growth Engine
5.2 Vaccines Market Overview
5.3 Recombinant Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Recombinant Vaccines: Geographic Segmentation
5.4 Viral Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Viral Vaccines: Geographic Segmentation
5.5 Polysaccharide Vaccines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Polysaccharide Vaccines: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Vaccines Market by Application
6.1 Vaccines Market Overview Snapshot and Growth Engine
6.2 Vaccines Market Overview
6.3 Rabies vaccine
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Rabies vaccine: Geographic Segmentation
6.4 Influenza vaccine
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Influenza vaccine: Geographic Segmentation
6.5 HPV vaccine
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 HPV vaccine: Geographic Segmentation
6.6 Hepatitis B
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Hepatitis B: Geographic Segmentation
6.7 Hepatitis A
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Hepatitis A: Geographic Segmentation
6.8 Leprosy vaccine
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Leprosy vaccine: Geographic Segmentation
6.9 Polio vaccine
6.9.1 Introduction and Market Overview
6.9.2 Historic and Forecasted Market Size (2017-2032F)
6.9.3 Key Market Trends, Growth Factors and Opportunities
6.9.4 Polio vaccine: Geographic Segmentation
6.10 JE vaccine
6.10.1 Introduction and Market Overview
6.10.2 Historic and Forecasted Market Size (2017-2032F)
6.10.3 Key Market Trends, Growth Factors and Opportunities
6.10.4 JE vaccine: Geographic Segmentation
6.11 Others
6.11.1 Introduction and Market Overview
6.11.2 Historic and Forecasted Market Size (2017-2032F)
6.11.3 Key Market Trends, Growth Factors and Opportunities
6.11.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Vaccines Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Vaccines Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Vaccines Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GSK
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SANOFI
7.4 MERCK
7.5 PFIZER
7.6 NOVARTIS(GSK)
7.7 CSL
7.8 MEDIMMUNE LLC
7.9 JANDJ(CRUCELL)
7.10 CHINA NATIONAL BIOTEC
7.11 TIANTAN
7.12 HUALAN
7.13 KANGTAI
7.14 HISSEN
7.15 JINTAN
Chapter 8: Global Vaccines Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Recombinant Vaccines
8.2.2 Viral Vaccines
8.2.3 Polysaccharide Vaccines
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Rabies vaccine
8.3.2 Influenza vaccine
8.3.3 HPV vaccine
8.3.4 Hepatitis B
8.3.5 Hepatitis A
8.3.6 Leprosy vaccine
8.3.7 Polio vaccine
8.3.8 JE vaccine
8.3.9 Others
Chapter 9: North America Vaccines Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Recombinant Vaccines
9.4.2 Viral Vaccines
9.4.3 Polysaccharide Vaccines
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Rabies vaccine
9.5.2 Influenza vaccine
9.5.3 HPV vaccine
9.5.4 Hepatitis B
9.5.5 Hepatitis A
9.5.6 Leprosy vaccine
9.5.7 Polio vaccine
9.5.8 JE vaccine
9.5.9 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Vaccines Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Recombinant Vaccines
10.4.2 Viral Vaccines
10.4.3 Polysaccharide Vaccines
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Rabies vaccine
10.5.2 Influenza vaccine
10.5.3 HPV vaccine
10.5.4 Hepatitis B
10.5.5 Hepatitis A
10.5.6 Leprosy vaccine
10.5.7 Polio vaccine
10.5.8 JE vaccine
10.5.9 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Vaccines Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Recombinant Vaccines
11.4.2 Viral Vaccines
11.4.3 Polysaccharide Vaccines
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Rabies vaccine
11.5.2 Influenza vaccine
11.5.3 HPV vaccine
11.5.4 Hepatitis B
11.5.5 Hepatitis A
11.5.6 Leprosy vaccine
11.5.7 Polio vaccine
11.5.8 JE vaccine
11.5.9 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Vaccines Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Recombinant Vaccines
12.4.2 Viral Vaccines
12.4.3 Polysaccharide Vaccines
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Rabies vaccine
12.5.2 Influenza vaccine
12.5.3 HPV vaccine
12.5.4 Hepatitis B
12.5.5 Hepatitis A
12.5.6 Leprosy vaccine
12.5.7 Polio vaccine
12.5.8 JE vaccine
12.5.9 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Vaccines Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Recombinant Vaccines
13.4.2 Viral Vaccines
13.4.3 Polysaccharide Vaccines
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Rabies vaccine
13.5.2 Influenza vaccine
13.5.3 HPV vaccine
13.5.4 Hepatitis B
13.5.5 Hepatitis A
13.5.6 Leprosy vaccine
13.5.7 Polio vaccine
13.5.8 JE vaccine
13.5.9 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Vaccines Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Recombinant Vaccines
14.4.2 Viral Vaccines
14.4.3 Polysaccharide Vaccines
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Rabies vaccine
14.5.2 Influenza vaccine
14.5.3 HPV vaccine
14.5.4 Hepatitis B
14.5.5 Hepatitis A
14.5.6 Leprosy vaccine
14.5.7 Polio vaccine
14.5.8 JE vaccine
14.5.9 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Vaccines Scope:
|
Report Data
|
Vaccines Market
|
|
Vaccines Market Size in 2025
|
USD XX million
|
|
Vaccines CAGR 2025 - 2032
|
XX%
|
|
Vaccines Base Year
|
2024
|
|
Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, JandJ(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan.
|
|
Key Segments
|
By Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
By Applications
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
|
